These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3806905)

  • 21. Liposomal drug delivery.
    Allison SD
    J Infus Nurs; 2007; 30(2):89-95; quiz 120. PubMed ID: 17413493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Developments in Liposomal Drug Delivery.
    Pattni BS; Chupin VV; Torchilin VP
    Chem Rev; 2015 Oct; 115(19):10938-66. PubMed ID: 26010257
    [No Abstract]   [Full Text] [Related]  

  • 23. [Liposomes].
    Puisieux F
    Ann Pharm Fr; 1983; 41(1):3-13. PubMed ID: 6354044
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological properties of liposomes and their practical application].
    Halyts'ka SM; Nikol's'kyĭ IS
    Fiziol Zh (1994); 2008; 54(5):99-108. PubMed ID: 19058519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Old drugs in new clothing.
    Gregoriadis G
    Nature; 1984 Jul 19-25; 310(5974):186-7. PubMed ID: 6462205
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of liposomes as carriers in the transport of substances of biological value to cells].
    Zietkiewicz E; Słomski R
    Postepy Biochem; 1984; 30(1-2):149-72. PubMed ID: 6397750
    [No Abstract]   [Full Text] [Related]  

  • 27. Early approval for two lipid-based drugs.
    Baker R
    BETA; 1995 Dec; ():4. PubMed ID: 11363009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of drug-containing liposomes to the duration of the intramuscular absorption of water-soluble drugs in rats.
    Arakawa E; Imai Y; Kobayashi H; Okumura K; Sezaki H
    Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2218-22. PubMed ID: 1212751
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and characterization of oral liposomes of vegetal ceramide based amphotericin B having enhanced dry solubility and solubility.
    Skiba-Lahiani M; Hallouard F; Mehenni L; Fessi H; Skiba M
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():145-9. PubMed ID: 25579907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal agents. Part I. Amphotericin B preparations and flucytosine.
    Patel R
    Mayo Clin Proc; 1998 Dec; 73(12):1205-25. PubMed ID: 9868423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physico-chemical medicine and therapeutic physical factors].
    Ulashchik VS
    Vopr Kurortol Fizioter Lech Fiz Kult; 1985; (4):1-6. PubMed ID: 4060652
    [No Abstract]   [Full Text] [Related]  

  • 32. Preliminary observations on the absorption of liposome-encapsulated drug by the intestinal lymphatics.
    Ueda CT; Nickols JG; Schmelter RF
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):487-98. PubMed ID: 7268193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal drug delivery system from laboratory to clinic.
    Kshirsagar NA; Pandya SK; Kirodian GB; Sanath S
    J Postgrad Med; 2005; 51 Suppl 1():S5-15. PubMed ID: 16519249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Possibility of the unification of directed drug transport as illustrated by liposome transport to target antigens].
    Trubetskoĭ VS; Berdichevskiĭ VR; Efremov EE; Torchilin VP; Smirnov VN
    Biull Eksp Biol Med; 1986 Sep; 102(9):305-7. PubMed ID: 3756331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
    Craddock C; Anson J; Chu P; Dodgson A; Duncan N; Gomez C; Mehta J; Sadullah S; Subudhi C; Yin JL
    Expert Opin Drug Saf; 2010 Jan; 9(1):139-47. PubMed ID: 19947901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.
    Amato VS; Rabello A; Rotondo-Silva A; Kono A; Maldonado TP; Alves IC; Floeter-Winter LM; Neto VA; Shikanai-Yasuda MA
    Acta Trop; 2004 Oct; 92(2):127-32. PubMed ID: 15350864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid formulations of amphotericin B.
    Dix SP; Andriole VT
    Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of liposomal amphotericin B in the treatment of systemic fungal infections.
    Patterson TF; Andriole VT
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S63-8. PubMed ID: 2693111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomes as delivery system for doxorubicin in cancer chemotherapy.
    Storm G
    Pharm Weekbl Sci; 1988 Dec; 10(6):288-90. PubMed ID: 3211705
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transferrin conjugates in the anticancer therapy].
    Lubgan D; Marczak A; Distel L; Jóźwiak Z
    Postepy Biochem; 2006; 52(1):72-9. PubMed ID: 16869304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.